Difference between revisions of "Team:ASIJ TOKYO"
| Line 3,134: | Line 3,134: | ||
#banner { | #banner { | ||
| − | |||
| − | |||
padding: 14em 0 14em 0 ; | padding: 14em 0 14em 0 ; | ||
| + | background-image: linear-gradient(to top, rgba(46, 49, 65, 0.8), rgba(46, 49, 65, 0.8)), url("../../images/bg.jpg"); | ||
background-size: auto, cover; | background-size: auto, cover; | ||
background-position: center, center; | background-position: center, center; | ||
| Line 3,217: | Line 3,216: | ||
#wrapper > header { | #wrapper > header { | ||
| − | |||
| − | |||
padding: 11em 0 2.25em 0 ; | padding: 11em 0 2.25em 0 ; | ||
} | } | ||
| Line 3,228: | Line 3,225: | ||
#wrapper > header h2 { | #wrapper > header h2 { | ||
| − | |||
| − | |||
border-bottom: solid 2px rgba(255, 255, 255, 0.125); | border-bottom: solid 2px rgba(255, 255, 255, 0.125); | ||
font-size: 2em; | font-size: 2em; | ||
| Line 3,248: | Line 3,243: | ||
#wrapper > header { | #wrapper > header { | ||
| + | padding: 9em 0 6.25em 0 ; | ||
background-color: #2e3141; | background-color: #2e3141; | ||
background-image: linear-gradient(to top, rgba(46, 49, 65, 0.8), rgba(46, 49, 65, 0.8)), url("../../images/bg.jpg"); | background-image: linear-gradient(to top, rgba(46, 49, 65, 0.8), rgba(46, 49, 65, 0.8)), url("../../images/bg.jpg"); | ||
| − | |||
background-size: auto, cover; | background-size: auto, cover; | ||
background-position: center, 0% 30%; | background-position: center, 0% 30%; | ||
| Line 3,261: | Line 3,256: | ||
#wrapper > header { | #wrapper > header { | ||
| − | |||
| − | |||
padding: 11em 3em 7.375em 3em ; | padding: 11em 3em 7.375em 3em ; | ||
background-size: auto, cover; | background-size: auto, cover; | ||
| Line 3,294: | Line 3,287: | ||
.wrapper { | .wrapper { | ||
| + | background-color: #2e3141; | ||
margin: 6.5em 0; | margin: 6.5em 0; | ||
position: relative; | position: relative; | ||
| Line 3,301: | Line 3,295: | ||
background-image: url("data:image/svg+xml;charset=utf8,%3Csvg xmlns='http://www.w3.org/2000/svg' width='100' height='100' viewBox='0 0 100 100' preserveAspectRatio='none'%3E%3Cpolygon points='0,100 100,0 100,100' style='fill:%232e3141%3B' /%3E%3C/svg%3E"); | background-image: url("data:image/svg+xml;charset=utf8,%3Csvg xmlns='http://www.w3.org/2000/svg' width='100' height='100' viewBox='0 0 100 100' preserveAspectRatio='none'%3E%3Cpolygon points='0,100 100,0 100,100' style='fill:%232e3141%3B' /%3E%3C/svg%3E"); | ||
} | } | ||
| − | |||
.wrapper:before { | .wrapper:before { | ||
| Line 3,312: | Line 3,305: | ||
.wrapper:before, .wrapper:after { | .wrapper:before, .wrapper:after { | ||
| − | |||
background-repeat: no-repeat; | background-repeat: no-repeat; | ||
background-size: 100% 100%; | background-size: 100% 100%; | ||
| Line 3,480: | Line 3,472: | ||
margin: 0 0 0em 0em; | margin: 0 0 0em 0em; | ||
} | } | ||
| + | |||
| + | .wrapper.spotlight.style1 { | ||
| + | background-color: #45558d; | ||
| + | } | ||
| + | |||
| + | .wrapper.spotlight.style1:before, .wrapper.spotlight.style2:after { | ||
| + | background-image: url("data:image/svg+xml;charset=utf8,%3Csvg xmlns='http://www.w3.org/2000/svg' width='100' height='100' viewBox='0 0 100 100' preserveAspectRatio='none'%3E%3Cpolygon points='0,100 100,0 100,100' style='fill:%2345558d%3B' /%3E%3C/svg%3E"); | ||
| + | } | ||
| + | |||
| + | .wrapper.spotlight.style1:before { | ||
| + | box-shadow: inset 0 -1px 0 0 #45558d, 0 1px 0 0 #45558d; | ||
| + | } | ||
| + | |||
| + | .wrapper.spotlight.style1:after { | ||
| + | box-shadow: inset 0 -1px 0 0 #45558d, 0 1px 0 0 #45558d; | ||
| + | } | ||
.wrapper.spotlight.style2 { | .wrapper.spotlight.style2 { | ||
| Line 4,064: | Line 4,072: | ||
<!-- Banner --> | <!-- Banner --> | ||
<section id="banner"> | <section id="banner"> | ||
| + | <h1></h1> | ||
<div class="inner"> | <div class="inner"> | ||
Revision as of 09:24, 31 October 2017
Description
Colorectal cancer remains the second most lethal cancer in the United States, often beginning as benign polyps in the colon and rectum. Despite relative ease of treatment, cases of CRC are usually detected in its late stages, rendering care difficult. CRC results from the mutation of multiple genes involved with the regulation of cell proliferation and DNA repair, with the ASIJ iGEM team focusing primarily on the Wnt pathway. The activation of the Wnt pathway specifically inhibits the degradation of beta-catenin, a protein that triggers the mutation of oncogenes and TSG’s. Through detection of these mutated genes and their subsequent downstream proteins, our team aims to develop an early screening method that can be adapted to a CRC detecting home-kit.
